Insider · CIK 0001577014

Jason P Rhodes

Files at: DYN, REPL. On EDGAR ↗

Period1M 3M 6M 1Y 2Y All datashares as filed — not split-adjusted

Open-market buys & salesbuys $0 · 0sales $99.4M · 4net −$99.4M

Reported trades — common stock

Trade	Reported (ET)	Company	Shares	Avg price	Total	Owned after	Δ stake	Flags
Aug 13, 2026 SForm 4 →	Aug 17, 5:30 pm EDT	Dyne Therapeutics, Inc.DYN	2,586,928	$25.20	$65,184,894	428,946	−85.8%	10b5-1
Jul 6, 2026 SForm 4 →	Jul 8, 5:35 pm EDT	Dyne Therapeutics, Inc.DYN	777,451	$22.97	$17,858,492	2,962	−99.6%	10b5-1
Jun 26, 2026 SForm 4 →	Jun 30, 7:05 pm EDT	Dyne Therapeutics, Inc.DYN	504,695	$21.23	$10,712,550	975,931	−34.1%	10b5-1
Jun 23, 2026 SForm 4 →	Jun 26, 8:40 am EDT	Dyne Therapeutics, Inc.DYN	267,760	$21.09	$5,646,497	1,081,044	−19.9%	10b5-1 late
Jul 24, 2018 CForm 4 →	Jul 26, 5:19 pm EDT	Replimune Group, Inc.REPL	4,453,386	—	—	4,453,386	—	plan?

Reported trades — derivatives (options, RSUs, warrants)

Trade	Reported (ET)	Company	Shares	Avg price	Total	Owned after	Δ stake	Flags
Jun 5, 2026 AForm 4 →	Jun 9, 5:13 pm EDT	Dyne Therapeutics, Inc.DYN	35,152	—	—	35,152	—
Jul 24, 2018 ACForm 4 →	Jul 26, 5:19 pm EDT	Replimune Group, Inc.REPL	4,466,886	—	—	13,500	—